drugset / Trial / NCT04754451

The Effect of Lidocaine Patch for Postoperative Pain

NCT04754451 ↗

Phase 4 Completed 32 enrolled BON WOOK KOO SK Chemicals Co., Ltd. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The lidocaine patch is currently only permitted for post herpetic neuralgia but the investigators want to study its effectiveness in post operative pain after inguinal herniorrhaphy

Timeline

Start
2021-03-15
Primary completion
2022-11-23
Completion
2022-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 5 % Topical

Indications

No indication recorded.